FDA statement on BPA raises concerns amongst Endocrine Society experts

28 Feb 2018


The Endocrine Society expresses disappointment regarding the FDA statement on BPA safety, highlighting that the CLARITY-BPA study does not examine key areas of concern. 

Newswise


Related Topics

Endocrine-Disrupting Chemicals

Share this story